Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells

J Immunol. 2004 Aug 1;173(3):1535-48. doi: 10.4049/jimmunol.173.3.1535.

Abstract

Human plasmacytoid dendritic cells (PDC) are a major source of IFN-alpha upon exposure to enveloped viruses and TLR-7 and TLR-9 ligands. Although IFN regulatory factor-7 (IRF-7) is known to play an essential role in virus-activated transcription of IFN-alpha genes, the molecular mechanisms of IFN-alpha production in human PDC remain poorly understood. We and others have recently reported high constitutive levels of IRF-7 expression in PDC as compared with other PBMC. In this study, we demonstrate that both LPS and HSV up-regulate the expression of IRF-7 in PDC, and that this enhancement of IRF-7 is dependent on NF-kappa B activation. The NF-kappa B inhibitors MG132 and pyrrolidinedithiocarbamate efficiently inhibited the induction of IRF-7 by HSV or LPS, and also down-regulated the constitutive expression of IRF-7 in PDC and blocked the HSV-induced production of IFN-alpha. In addition, we found that nuclear translocation of IRF-7 occurred rapidly in response to HSV stimulation, but not in response to LPS, which is consistent with the stimulation of IFN-alpha production by virus and not by LPS. Although LPS by itself was not able to induce IFN-alpha production, it led to rapid up-regulation of TLR-4 on PDC and increased the magnitude and accelerated the kinetics of HSV-induced IFN-alpha production in PDC, providing a mechanism that might be operative in a scenario of mixed infection. In contrast to the current concept of IFN-alpha regulation established in cell lines, this study strongly supports the immediate availability of high constitutive levels of IRF-7 expression in PDC, and suggests an activation required for IRF-7 that contributes to IFN-alpha production in virus-stimulated PDC.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Active Transport, Cell Nucleus
  • Animals
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Cells, Cultured / virology
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / physiology*
  • Dendritic Cells / drug effects*
  • Dendritic Cells / metabolism
  • Dendritic Cells / virology
  • Dogs
  • Herpesvirus 1, Human / physiology*
  • Humans
  • Influenza A virus / physiology
  • Interferon Regulatory Factor-7
  • Interferon-alpha / biosynthesis*
  • Interferon-alpha / genetics
  • Kidney
  • Leupeptins / pharmacology
  • Lipopolysaccharides / pharmacology*
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / genetics
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / physiology
  • Polymyxin B / pharmacology
  • Pyrrolidines / pharmacology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptors, Cell Surface / biosynthesis
  • Receptors, Cell Surface / genetics
  • Sendai virus / physiology
  • Thiocarbamates / pharmacology
  • Toll-Like Receptor 4
  • Toll-Like Receptor 7
  • Toll-Like Receptor 9
  • Toll-Like Receptors
  • Transcription, Genetic

Substances

  • DNA-Binding Proteins
  • IRF7 protein, human
  • Interferon Regulatory Factor-7
  • Interferon-alpha
  • Leupeptins
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • NF-kappa B
  • Pyrrolidines
  • RNA, Messenger
  • Receptors, Cell Surface
  • TLR4 protein, human
  • TLR7 protein, human
  • TLR9 protein, human
  • Thiocarbamates
  • Toll-Like Receptor 4
  • Toll-Like Receptor 7
  • Toll-Like Receptor 9
  • Toll-Like Receptors
  • pyrrolidine dithiocarbamic acid
  • Polymyxin B
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde